Caprock »

Adma Biologics shares owned by Caprock

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Caprock from 13F filings

Historical chart of Caprock investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Caprock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Caprock

Quarter filed Position value Share count Share price at filing
2024-03-31 $90k 14k 6.60
2023-12-31 $55k 12k 4.52
2023-09-30 $44k 12k 3.58
2023-06-30 $38k 10k 3.69

More positions owned by Caprock

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Apple (AAPL)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
NVIDIA Corporation (NVDA)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Amazon (AMZN)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Ishares Tr Russell 3000 Etf (IWV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Caprock

Top funds holding Adma Biologics

Vanguard Group
D. E. Shaw & Co
Perceptive Advisors
AWM Investment Company
Dimensional Fund Advisors
Millennium Management
Assenagon Asset Management
Two Sigma Investments
Deutsche Bank Aktiengesellschaft
Two Sigma Advisers
Oberweis Asset Management
Goldman Sachs Group
Charles Schwab Investment Management
Bank of America Corporation
Tang Capital Management

View all funds holding Adma Biologics